Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines
NEW YORK and SANTA BARBARA, CA, July 22, 2024 — Phytanix Bio, an innovative pharmaceutical company dedicated to the development of therapeutics based on cannabinoid

